nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—Syncope—Mycophenolic acid—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tiotropium—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tiotropium—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tiotropium—Myalgia—Leflunomide—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tiotropium—Chest pain—Leflunomide—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tiotropium—Arthralgia—Leflunomide—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Tiotropium—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Tiotropium—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Tiotropium—Constipation—Captopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Tiotropium—Palpitations—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Tiotropium—Skin disorder—Azathioprine—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Tiotropium—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Tiotropium—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Tiotropium—Dry mouth—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Tiotropium—Cough—Mycophenolic acid—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Tiotropium—Back pain—Lisinopril—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Tiotropium—Vomiting—Pentoxifylline—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Tiotropium—Rash—Pentoxifylline—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Tiotropium—Hypertension—Mycophenolic acid—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Tiotropium—Dermatitis—Pentoxifylline—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Tiotropium—Headache—Pentoxifylline—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Tiotropium—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Tiotropium—Myalgia—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Tiotropium—Chest pain—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Tiotropium—Infection—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Tiotropium—Vision blurred—Lisinopril—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Tiotropium—Gastrointestinal pain—Captopril—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Tiotropium—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Tiotropium—Nervous system disorder—Leflunomide—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Tiotropium—Pruritus—Mometasone—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tiotropium—Tachycardia—Leflunomide—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tiotropium—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tiotropium—Skin disorder—Leflunomide—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Tiotropium—Angioedema—Lisinopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Tiotropium—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Tiotropium—Abdominal pain—Captopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Tiotropium—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Tiotropium—Oedema—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Tiotropium—Dry skin—Prednisone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Tiotropium—Nausea—Pentoxifylline—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Tiotropium—Infection—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Tiotropium—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Tiotropium—Syncope—Lisinopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Tiotropium—Shock—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Tiotropium—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Tiotropium—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Tiotropium—Palpitations—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Tiotropium—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Tiotropium—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Tiotropium—Loss of consciousness—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Tiotropium—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Tiotropium—Cough—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Tiotropium—Insomnia—Leflunomide—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Tiotropium—Paraesthesia—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Tiotropium—Chest pain—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Tiotropium—Arthralgia—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Tiotropium—Myalgia—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Tiotropium—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Tiotropium—Dyspepsia—Leflunomide—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Tiotropium—Vomiting—Mometasone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Tiotropium—Dry mouth—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Tiotropium—Rash—Mometasone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Tiotropium—Dermatitis—Mometasone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Tiotropium—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Tiotropium—Headache—Mometasone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Tiotropium—Insomnia—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Tiotropium—Oedema—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Tiotropium—Pruritus—Captopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Tiotropium—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Tiotropium—Constipation—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Tiotropium—Infection—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Tiotropium—Shock—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Tiotropium—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Tiotropium—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Tiotropium—Tachycardia—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Tiotropium—Abdominal pain—Azathioprine—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Tiotropium—Skin disorder—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Tiotropium—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Tiotropium—Nausea—Mometasone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Tiotropium—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Tiotropium—Constipation—Mycophenolic acid—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Tiotropium—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Tiotropium—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Tiotropium—Hyperglycaemia—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Tiotropium—Cough—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Tiotropium—Dizziness—Captopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Tiotropium—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Tiotropium—Urticaria—Leflunomide—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Tiotropium—Abdominal pain—Leflunomide—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Tiotropium—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Tiotropium—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Tiotropium—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Tiotropium—Hypersensitivity—Azathioprine—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tiotropium—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tiotropium—Insomnia—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tiotropium—Paraesthesia—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Tiotropium—Vomiting—Captopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Tiotropium—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Tiotropium—Rash—Captopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Tiotropium—Dermatitis—Captopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Tiotropium—Headache—Captopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Tiotropium—Dyspepsia—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Tiotropium—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Tiotropium—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Tiotropium—Infection—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Tiotropium—Shock—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Tiotropium—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Tiotropium—Hypersensitivity—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Tiotropium—Constipation—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Tiotropium—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Tiotropium—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Tiotropium—Nausea—Captopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Tiotropium—Pruritus—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Tiotropium—Connective tissue disorder—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Tiotropium—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Tiotropium—Dysuria—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Tiotropium—Dizziness—Azathioprine—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Tiotropium—Urticaria—Lisinopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Tiotropium—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Tiotropium—Abdominal pain—Lisinopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Tiotropium—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Tiotropium—Pruritus—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Tiotropium—Vomiting—Azathioprine—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Tiotropium—Eye disorder—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Tiotropium—Rash—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Tiotropium—Dermatitis—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Tiotropium—Headache—Azathioprine—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Tiotropium—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Tiotropium—Dizziness—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Tiotropium—Renal failure—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Tiotropium—Stomatitis—Methotrexate—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Tiotropium—Angiopathy—Prednisone—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Tiotropium—Immune system disorder—Prednisone—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Tiotropium—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000985	0.000985	CcSEcCtD
Tiotropium—Arrhythmia—Prednisone—systemic scleroderma	0.000981	0.000981	CcSEcCtD
Tiotropium—Vomiting—Leflunomide—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Tiotropium—Hypersensitivity—Lisinopril—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Tiotropium—Dizziness—Mycophenolic acid—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Tiotropium—Epistaxis—Methotrexate—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Tiotropium—Rash—Leflunomide—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Tiotropium—Dermatitis—Leflunomide—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Tiotropium—Mental disorder—Prednisone—systemic scleroderma	0.000963	0.000963	CcSEcCtD
Tiotropium—Nausea—Azathioprine—systemic scleroderma	0.000962	0.000962	CcSEcCtD
Tiotropium—Headache—Leflunomide—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Tiotropium—Malnutrition—Prednisone—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Tiotropium—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000942	0.000942	CcSEcCtD
Tiotropium—Pruritus—Lisinopril—systemic scleroderma	0.00093	0.00093	CcSEcCtD
Tiotropium—Vomiting—Mycophenolic acid—systemic scleroderma	0.000928	0.000928	CcSEcCtD
Tiotropium—Rash—Mycophenolic acid—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Tiotropium—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000919	0.000919	CcSEcCtD
Tiotropium—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Tiotropium—Headache—Mycophenolic acid—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Tiotropium—Pharyngitis—Methotrexate—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Tiotropium—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00091	0.00091	CcSEcCtD
Tiotropium—Nausea—Leflunomide—systemic scleroderma	0.000909	0.000909	CcSEcCtD
Tiotropium—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000907	0.000907	CcSEcCtD
Tiotropium—Vision blurred—Prednisone—systemic scleroderma	0.000901	0.000901	CcSEcCtD
Tiotropium—Urethral disorder—Methotrexate—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Tiotropium—Visual impairment—Methotrexate—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Tiotropium—Angioedema—Prednisone—systemic scleroderma	0.000874	0.000874	CcSEcCtD
Tiotropium—Dizziness—Lisinopril—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Tiotropium—Nausea—Mycophenolic acid—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Tiotropium—Eye disorder—Methotrexate—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Tiotropium—Syncope—Prednisone—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Tiotropium—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisone—systemic scleroderma	0.000841	0.000841	CcSEcCtD
Tiotropium—Vomiting—Lisinopril—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Tiotropium—Angiopathy—Methotrexate—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Tiotropium—Immune system disorder—Methotrexate—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Tiotropium—Rash—Lisinopril—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Tiotropium—Dermatitis—Lisinopril—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Tiotropium—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Tiotropium—Hypertension—Prednisone—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Tiotropium—Headache—Lisinopril—systemic scleroderma	0.000823	0.000823	CcSEcCtD
Tiotropium—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000815	0.000815	CcSEcCtD
Tiotropium—Arthralgia—Prednisone—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Tiotropium—Myalgia—Prednisone—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Tiotropium—Mental disorder—Methotrexate—systemic scleroderma	0.000804	0.000804	CcSEcCtD
Tiotropium—Malnutrition—Methotrexate—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Tiotropium—Nausea—Lisinopril—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Tiotropium—Oedema—Prednisone—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Tiotropium—Infection—Prednisone—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Tiotropium—Back pain—Methotrexate—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Tiotropium—Shock—Prednisone—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Tiotropium—Nervous system disorder—Prednisone—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Tiotropium—Tachycardia—Prednisone—systemic scleroderma	0.000762	0.000762	CcSEcCtD
Tiotropium—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Tiotropium—Skin disorder—Prednisone—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Tiotropium—Vision blurred—Methotrexate—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Tiotropium—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Tiotropium—Rash—Mycophenolate mofetil—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Tiotropium—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Tiotropium—Headache—Mycophenolate mofetil—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Tiotropium—Insomnia—Prednisone—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Tiotropium—Paraesthesia—Prednisone—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Tiotropium—Cough—Methotrexate—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Tiotropium—Dyspepsia—Prednisone—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Tiotropium—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Tiotropium—Arthralgia—Methotrexate—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Tiotropium—Myalgia—Methotrexate—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Tiotropium—Chest pain—Methotrexate—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Tiotropium—Constipation—Prednisone—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Tiotropium—Infection—Methotrexate—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Tiotropium—Nervous system disorder—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Tiotropium—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Tiotropium—Skin disorder—Methotrexate—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Tiotropium—Urticaria—Prednisone—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Tiotropium—Abdominal pain—Prednisone—systemic scleroderma	0.000617	0.000617	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Tiotropium—Insomnia—Methotrexate—systemic scleroderma	0.00059	0.00059	CcSEcCtD
Tiotropium—Paraesthesia—Methotrexate—systemic scleroderma	0.000586	0.000586	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisone—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Tiotropium—Dyspepsia—Methotrexate—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Tiotropium—Pruritus—Prednisone—systemic scleroderma	0.000552	0.000552	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Tiotropium—Urticaria—Methotrexate—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Tiotropium—Dizziness—Prednisone—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Tiotropium—Abdominal pain—Methotrexate—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Tiotropium—Vomiting—Prednisone—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Tiotropium—Rash—Prednisone—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Tiotropium—Dermatitis—Prednisone—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Tiotropium—Headache—Prednisone—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Tiotropium—Hypersensitivity—Methotrexate—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Tiotropium—Nausea—Prednisone—systemic scleroderma	0.000464	0.000464	CcSEcCtD
Tiotropium—Pruritus—Methotrexate—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Tiotropium—Dizziness—Methotrexate—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Tiotropium—Vomiting—Methotrexate—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Tiotropium—Rash—Methotrexate—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Tiotropium—Dermatitis—Methotrexate—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Tiotropium—Headache—Methotrexate—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Tiotropium—Nausea—Methotrexate—systemic scleroderma	0.000387	0.000387	CcSEcCtD
